[Personalized systemic treatment of metastatic colorectal cancer].

Personalisierte Systemtherapie beim metastasierten kolorektalen Karzinom.

Journal

Der Internist
ISSN: 1432-1289
Titre abrégé: Internist (Berl)
Pays: Germany
ID NLM: 0264620

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 5 6 2020
medline: 21 7 2020
entrez: 5 6 2020
Statut: ppublish

Résumé

This article deals with the treatment of metastatic colorectal cancer (stage IV). The treatment goals and approaches are determined by the resectability status of the metastases: resectable liver and lung metastases are primarily resected and perioperative chemotherapy appears to be dispensable. In potentially resectable metastases, a conversion therapy is attempted to enable a potentially curative resection. In the case of nonresectability the treatment goal is palliative. Induction and maintenance therapy as well as drug holidays are suggested in an attempt to achieve extended survival while maintaining the quality of life, beginning with the best possible individual treatment. For some patients with stage IV, molecular targeted therapies are available. The study situation and approval status are dealt with in detail. With improved molecular characterization of tumors the treatment can be further individualized.

Identifiants

pubmed: 32494899
doi: 10.1007/s00108-020-00808-x
pii: 10.1007/s00108-020-00808-x
doi:

Types de publication

Journal Article

Langues

ger

Sous-ensembles de citation

IM

Pagination

699-710

Auteurs

R-D Hofheinz (RD)

TagesTherapieZentrum, Interdisziplinäres Tumorzentrum, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland. ralf.hofheinz@umm.de.

S Stintzing (S)

Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie (CCM), Charité - Universitätsmedizin Berlin, Berlin, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH